D. Weisenburger

D. Weisenburger, R. Pfeiffer, C. Lynch, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Burkitt lymphoma risk in U.S. solid organ transplant recipients

D. Weisenburger, M. Goodman, C. Lynch, 2013, American journal of hematology.

Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States)

D. Weisenburger, A. Blair, M. Ward, 1994, Cancer Causes & Control.

Clinical significance of hematologic parameters in non‐Hodgkin's lymphoma at diagnosis

D. Weisenburger, J. Armitage, M. Bast, 1991, Cancer.

Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference

R. Sinha, D. Weisenburger, N. Rothman, 1997, International journal of cancer.

Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma

D. Weisenburger, J. Vose, E. Cavalieri, 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Hereditary chronic lymphocytic leukemia: an extended family study and literature review.

D. Weisenburger, W. Sanger, H. Lynch, 2002, American journal of medical genetics.

Chromosomal abnormalities in Hodgkin's disease.

D. Weisenburger, J. Armitage, K. Maclennan, 1989, Blood.

Recurrent activating mutations of CD28 in peripheral T-cell lymphomas

L. Staudt, A. Rosenwald, W. Chan, 2016, Leukemia.

Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.

D. Weisenburger, J. Armitage, M. Bast, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.

D. Weisenburger, J. Armitage, P. Bierman, 1990, Blood.

The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population

Jean F. Garcia-Gomez, D. Weisenburger, M. Maiers, 2019, Leukemia & lymphoma.

New Genomic Model Integrating Clinical Factors and Gene Mutations to Predict Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Rebecca Ottesen, Raju Pillai, Jasmine Zain, 2018, Blood.

Allogeneic Hematopoietic Cell Transplantation Outcomes in Patients Carrying Isocitrate Dehydrogenase Mutations.

D. Weisenburger, G. Marcucci, I. Aldoss, 2019, Clinical lymphoma, myeloma & leukemia.

Chromosomal abnormalities in Hodgkin's disease.

D. Weisenburger, J. Armitage, K. Maclennan, 1989, Blood.

Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC)

D. Weisenburger, N. Camp, G. Giles, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach

R. Sinha, D. Weisenburger, C. Abnet, 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

D. Weisenburger, J. Cerhan, Alexandra G. Smith, 2014, Journal of the National Cancer Institute. Monographs.

Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

D. Weisenburger, C. Flowers, A. Feldman, 2014, Journal of the National Cancer Institute. Monographs.

Agricultural pesticide use and adenocarcinomas of the stomach and oesophagus

D. Weisenburger, M. Ward, R. Markin, 2004, Occupational and Environmental Medicine.

Integrative assessment of multiple pesticides as risk factors for non-Hodgkin’s lymphoma among men

D. Weisenburger, L. Burmeister, A. Blair, 2003, Occupational and environmental medicine.

Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma

Tyler A. Herek, A. Rosenwald, W. Chan, 2021, Clinical Cancer Research.

Tobacco and non-Hodgkin's lymphoma: combined analysis of three case-control studies (United States)

D. Weisenburger, A. Blair, S. Zahm, 1997, Cancer Causes & Control.

Genetic and immunopathological findings in a lymphoma family.

D. Weisenburger, H. Lynch, P. Watson, 1989, British Journal of Cancer.

based on gene expression profiling Cyclin D 1-negative mantle cell lymphoma : a clinicopathological study

L. Staudt, A. Rosenwald, W. Chan, 2005 .

Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage.

W. Chan, D. Weisenburger, W. Sanger, 2007, American journal of clinical pathology.

Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21).

D. Weisenburger, J. Armitage, P. Bierman, 1988, Journal of the National Cancer Institute.

Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.

Dennis P. Robinson, D. Weisenburger, J. Cerhan, 2014, Journal of the National Cancer Institute. Monographs.

Risk of myeloid neoplasms after solid organ transplantation

D. Weisenburger, R. Pfeiffer, C. Lynch, 2014, Leukemia.

Meat intake and risk of non-Hodgkin lymphoma

D. Weisenburger, Sonali M. Smith, N. Ollberding, 2012, Cancer Causes & Control.

Assessing Cancer Treatment Information Using Medicare and Hospital Discharge Data among Women with Non-Hodgkin Lymphoma in a Los Angeles County Case–Control Study

D. Weisenburger, L. Bernstein, P. Seibold, 2020, Cancer Epidemiology, Biomarkers & Prevention.

IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

L. Staudt, W. Chan, T. Greiner, 2015 .

A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus.

D. Weisenburger, K. Fu, W. Klapper, 2006, Blood.

Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions.

D. Weisenburger, J. Armitage, D. Howe, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation.

D. Weisenburger, J. Armitage, P. Bierman, 1989, Blood.

Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression in follicular lymphoma

D. Weisenburger, B. Dave, Rakesh K. Singh, 2014, Leukemia & lymphoma.

Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry.

L. Staudt, A. Rosenwald, W. Chan, 2019, Blood.

Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma

D. Weisenburger, J. Vose, S. Joshi, 2012, Cancer Immunology, Immunotherapy.

Targeting CD30 in Malignant Tissues: Challenges in Detection and Clinical Applications

D. Weisenburger, M. Wasik, Gretchen S. Jimenez, 2013, Pathobiology.

Rapid development of HPV-mediated oropharyngeal squamous cell carcinoma in the setting of immune suppression following autologous stem cell transplantation for Hodgkin lymphoma

D. Weisenburger, A. Nademanee, Huiqing Wu, 2017 .

Stromal Tumor Microenvironment in Chronic Lymphocytic Leukemia: Regulation of Leukemic Progression

Christine E. Cutucache, D. Weisenburger, P. Bierman, 2013 .

Genome-wide miRNAprofiling of mantle cell lymphoma reveals a distinctsubgroup with poor prognosis

L. Staudt, A. Rosenwald, W. Chan, 2019 .

Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases.

B. Nathwani, D. Weisenburger, H. Rappaport, 1985, Human pathology.

Family with acute myelocytic leukemia, breast, ovarian, and gastrointestinal cancer.

D. Weisenburger, W. Sanger, S. Lipkin, 2002, Cancer genetics and cytogenetics.

Hair Dyes and Risk of Glioma Among Nebraska Women

D. Weisenburger, M. Ward, S. Zahm, 2005, Cancer Causes & Control.

B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS

D. Weisenburger, J. Cerhan, C. Flowers, 2022, Cancer Epidemiology, Biomarkers & Prevention.

Mantle cell lymphoma as a component of composite lymphoma: clinicopathologic parameters and biologic implications.

Michael L. Wang, D. Weisenburger, E. Campo, 2012, Human pathology.

Does asbestos exposure cause non-Hodgkin's lymphoma or related hematolymphoid cancers? A review of the epidemiologic literature.

D. Weisenburger, B. Chiu, 2002, Clinical lymphoma.

The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade.

W. Chan, T. Greiner, D. Weisenburger, 2002, American journal of clinical pathology.

Environmental epidemiology of non-Hodgkin's lymphoma in eastern Nebraska.

D. Weisenburger, 1990, American journal of industrial medicine.

Relative frequency of non‐Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases

B. Nathwani, D. Weisenburger, J. Armitage, 2016, British journal of haematology.

Medical history, lifestyle, family history, and occupational risk factors for adult acute lymphocytic leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

D. Weisenburger, C. Skibola, S. Berndt, 2014, Journal of the National Cancer Institute. Monographs.

Recurrent bone marrow aplasia secondary to nilotinib in a patient with chronic myeloid leukemia: A case report

D. Weisenburger, P. Aoun, Anamarija M. Perry, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Peripheral T‐cell lymphoma

B. Nathwani, D. Weisenburger, J. Armitage, 1989, Cancer.

Use of the World Health Organization (WHO) Classification of Non-Hodgkin's Lymphoma in Mumbai, India: A Review of 200 Consecutive Cases by a Panel of Five Expert Hematopathologists

B. Nathwani, D. Weisenburger, J. Armitage, 2004, Leukemia & lymphoma.

D. Weisenburger, J. Cigudosa, W. Sanger, 2002, Genes, chromosomes & cancer.

Nebraska , United States Agricultural pesticide use and risk of glioma in and

D. Weisenburger, J. Colt, R. Mccomb, 2005 .

Diffuse Large B-cell Lymphoma Arising in Nodular Lymphocyte Predominant Hodgkin Lymphoma. A Report of 21 Cases from the Nebraska Lymphoma Study Group

W. Chan, T. Greiner, D. Weisenburger, 2003, Leukemia & lymphoma.

CNOP for Diffuse Aggressive Non-Hodgkin's Lymphoma: The Nebraska Lymphoma Study Group Experience

T. Greiner, D. Weisenburger, J. Armitage, 2002, Leukemia & lymphoma.

Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy.

D. Weisenburger, J. Armitage, A. Kessinger, 1988, Blood.

A Pooled Analysis of Alcohol Consumption and Risk of Multiple Myeloma in the International Multiple Myeloma Consortium

D. Weisenburger, N. Camp, J. Spinelli, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Rapid Communication Epstein-Barr Viral Genome in Lymph Nodes from Patients with Hodgkin's Disease May Not Be Specific to Reed-Sternberg Cells

D. Weisenburger, D. Purtilo, R. Bashir, 2007 .

Hodgkin's disease: a monoclonal lymphoproliferative disorder?

W. Chan, D. Weisenburger, J. Delabie, 1995, Histopathology.

Noncutaneous peripheral T‐cell lymphoma histologically resembling mycosis fungoides

B. Nathwani, D. Weisenburger, S. Forman, 1982, Cancer.

Classification of non‐Hodgkin lymphoma in South‐eastern Europe: review of 632 cases from the international non‐Hodgkin lymphoma classification project

B. Nathwani, D. Weisenburger, J. Armitage, 2015, British journal of haematology.

Immunoblastic lymphadenopathy with pulmonary infiltrates, hypocomplementemia and vasculitis. A hyperimmune syndrome.

D. Weisenburger, J. Armitage, F. Dick, 1977, The American journal of medicine.

Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation.

D. Weisenburger, J. Armitage, P. Bierman, 1989, The American journal of medicine.

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.

D. Weisenburger, J. Armitage, P. Bierman, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1.

D. Weisenburger, R. Brynes, Wengang Chen, 2013, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

A Case-Control Study of Non-Hodgkin ' s Lymphoma and the Herbicide 2 , 4-Dichlorophenoxyacetic Acid ( 2 , 4-D ) in Eastern Nebraska Author ( s ) :

D. Weisenburger, P. Babbitt, A. Blair, 2011 .

Pathological classification of non-Hodgkin's lymphoma for epidemiological studies.

D. Weisenburger, 1992, Cancer research.

Diffuse Large B-Cell Lymphoma Subgroups Have Distinct Genetic Profiles that Influence Tumor Biology and Improve Gene Expression-Based Survival Prediction for the Lymphoma/Leukemia Molecular Profiling Project

Rita, Armitage, L. Staudt, 2005 .

High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma.

D. Weisenburger, J. Armitage, P. Bierman, 1989, Blood.

Novel therapy for therapy‐resistant mantle cell lymphoma: Multipronged approach with targeting of hedgehog signaling

D. Weisenburger, P. Bierman, J. Vose, 2012, International journal of cancer.

Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.

D. Weisenburger, J. Armitage, S. Mann, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dendritic Cell-based Therapy for Mantle Cell Lymphoma

D. Weisenburger, J. Vose, S. Joshi, 2007 .

Hedgehog-Induced Survival of B-Cell Chronic Lymphocytic Leukemia Cells in a Stromal Cell Microenvironment: A Potential New Therapeutic Target

D. Weisenburger, P. Bierman, R. Bociek, 2008, Molecular Cancer Research.

Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.

D. Weisenburger, R. Bociek, W. Sanger, 2007, International journal of molecular medicine.

Enhanced antiproliferative activity by metastatic RAW117 lymphoma cells

D. Weisenburger, S. Joshi, K. Brunson, 2005, Clinical and Experimental Metastasis.

Characterization of a newly established human burkitt's lymphoma cell line, OMA‐BL‐1

D. Weisenburger, W. Sanger, J. Sharp, 1991, International Journal of Cancer.

Effects of 2,4,5-trichlorophenoxyacetic acid, pentachlorophenol, methylprednisolone, and Freund's adjuvant on 2-hydroxyethylnitrosourea carcinogenesis in MRC-Wistar rats.

D. Weisenburger, M. Gross, S. Joshi, 1991, Journal of toxicology and environmental health.

2-Hydroxyethylnitrosourea induction of B cell lymphoma in female Swiss mice.

D. Weisenburger, S. Joshi, S. Mirvish, 1990, Cancer letters.

Ortho-quinones of benzene and estrogens induce hyperproliferation of human peripheral blood mononuclear cells

D. Weisenburger, S. Joshi, E. Cavalieri, 2006, Leukemia & lymphoma.

Familial multiple myeloma: a family study and review of the literature.

D. Weisenburger, W. Sanger, H. Lynch, 2001, Journal of the National Cancer Institute.

Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)

Bernd Hinzmann, Georg Beckmann, Reiner Siebert, 1999, Nature Genetics.

Mantle Cell Lymphoma With Plasma Cell Differentiation

W. Chan, T. Greiner, D. Weisenburger, 2006, The American journal of surgical pathology.

Front & Back Matter

D. Weisenburger, H. Watari, N. Sakuragi, 2013, Pathobiology.

High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma.

C. D. Wu, D. Weisenburger, P. Bierman, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma.

D. Weisenburger, J. Armitage, P. Bierman, 1989, Blood.

Peripheral T‐cell lymphoma A clinicopathologic study of a morphologically diverse entity

D. Weisenburger, V. Caggiano, M. Mackenzie, 1985, Cancer.

Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP

W. Chan, D. Weisenburger, D. Scott, 2020, Clinical Cancer Research.

Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma

W. Chan, D. Weisenburger, J. Niland, 2020, Leukemia.

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

L. Staudt, A. Rosenwald, D. Weisenburger, 2009, Haematologica.

Soluble interleukin 2 receptors in patients with malignant lymphoma.

D. Weisenburger, J. Armitage, D. Purtilo, 1988, Archives of Pathology & Laboratory Medicine.

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.

B. Nathwani, D. Weisenburger, J. Armitage, 2011, Blood.

Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice

Philipp W. Raess, L. Staudt, W. C. Chan, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: A case report

D. Weisenburger, W. Choi, W. Sanger, 2009, Cytometry. Part B, Clinical cytometry.

Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival

A. Rosenwald, D. Weisenburger, K. Fu, 2008, Leukemia & lymphoma.

Lymphomatous polyposis. A neoplasm of either follicular mantle or germinal center cell origin.

D. Weisenburger, M. Bast, J. Delabie, 1996, The American journal of surgical pathology.

Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with "Hodgkin's transformation".

W. Chan, D. Weisenburger, R. Gascoyne, 1998, Blood.

Richter's syndrome with different immunoglobulin light chain types. Molecular and cytogenetic features indicate a common clonal origin.

D. Weisenburger, J. Armitage, H. Nakamine, 1992, American journal of clinical pathology.

Glyphosate use and associations with non-Hodgkin lymphoma major histological sub-types: findings from the North American Pooled Project.

D. Weisenburger, J. Spinelli, P. Demers, 2019, Scandinavian journal of work, environment & health.

Phytanic acid and the risk of non-Hodgkin lymphoma.

D. Weisenburger, Sonali M. Smith, N. Ollberding, 2013, Carcinogenesis.

Dietary factors and risk of t(14;18)-defined subgroups of non-Hodgkin lymphoma

L. Hou, D. Weisenburger, B. Dave, 2008, Cancer Causes & Control.

Cigarette smoking, familial hematopoietic cancer, hair dye use, and risk of t(14;18)-defined subtypes of non-Hodgkin's lymphoma.

D. Weisenburger, J. Chmiel, B. Dave, 2007, American journal of epidemiology.

Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma.

D. Weisenburger, B. Dave, S. Gapstur, 2006, Blood.

Drinking Water and Dietary Sources of Nitrate and Nitrite and Risk of Glioma

D. Weisenburger, M. Ward, R. Mccomb, 2005, Journal of occupational and environmental medicine.

Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.

Angela Brooks-Wilson, Nathaniel Rothman, Anthony Staines, 2015, American journal of epidemiology.

Lymphoplasmacytic lymphoma. Report of a case with three monoclonal proteins derived from a single neoplastic clone

D. Weisenburger, J. Armitage, J. Linder, 1986, Cancer.

Prolymphocytic leukemia: Flow microfluorometric, immunologic, and cytogenetic observations

P. K. Berry, B. Nathwani, D. Weisenburger, 1980, American journal of hematology/oncology.

Follicular lymphoma polygenic risk score is associated with increased disease risk but improved overall survival among women in a population based case-control in Los Angeles County California.

D. Weisenburger, L. Bernstein, S. Neuhausen, 2020, Cancer epidemiology.

Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma.

W. Chan, D. Weisenburger, J. Armitage, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diffuse Large B-cell Lymphoma Arising in Nodular Lymphocyte Predominant Hodgkin Lymphoma: a Report of 21 Cases from the Nebraska Lymphoma Study Group

W. Chan, T. Greiner, D. Weisenburger, 2004, Leukemia & lymphoma.

Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.

W. Chan, D. Weisenburger, J. Armitage, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The tumor cells in nodular lymphocyte-predominant Hodgkin disease are clonally related to the large cell lymphoma occurring in the same individual. Direct demonstration by single cell analysis.

W. Chan, D. Weisenburger, T. Ohno, 2001, American journal of clinical pathology.

Concurrent lymphocyte predominance Hodgkin's disease and T-cell lymphoma. A report of three cases.

T. Greiner, D. Weisenburger, J. Delabie, 1996, The American journal of surgical pathology.

Sun sensitivity, indoor tanning and B‐cell non‐Hodgkin lymphoma risk among Caucasian women in Los Angeles County

D. Weisenburger, L. Bernstein, J. Lacey, 2017, British journal of haematology.

Preferential in-vitro growth and expansion of leukemic T lymphoblasts.

D. Weisenburger, W. Sanger, S. Joshi, 1988, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

lymphoma and prognostication in angioimmunoblastic T-cell lymphoma Molecular signatures to improve diagnosis in peripheral T-cell

W. Chan, T. Greiner, D. Weisenburger, 2013 .

LYMPHOID NEOPLASIA Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

W. Chan, T. Greiner, D. Weisenburger, 2010 .

Detection of the t(2;5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization.

D. Weisenburger, W. Sanger, D. Srivastava, 1997, Blood.

Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults.

W. Chan, D. Weisenburger, W. Sanger, 2004, Cancer genetics and cytogenetics.

Blastic transformation of mantle cell lymphoma with B-lymphoblastic features

D. Weisenburger, J. Murata-Collins, D. Cantu, 2019, Human Pathology: Case Reports.

IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

L. Staudt, W. Chan, T. Greiner, 2015 .

MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.

Bernhard Puppe, Jan Delabie, Randy D Gascoyne, 2011, Blood.

Molecular diagnosis of Burkitt's lymphoma.

Richard Simon, Kai Fu, Jan Delabie, 2006, The New England journal of medicine.

Cytotoxic peripheral T cell lymphoma arising in a patient with nodular lymphocyte predominant Hodgkin lymphoma: a case report

T. Greiner, D. Weisenburger, G. Caponetti, 2010, Journal of hematopathology.

NK cell lymphoma, nasal type, with massive lung involvement: a case report

D. Weisenburger, I. Aurer, M. Nola, 2010, Journal of hematopathology.

Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings.

D. Weisenburger, J. Armitage, W. Sanger, 1987, Blood.

Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10).

D. Weisenburger, W. Sanger, J. Karp, 1988, Leukemia.

Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions.

W. Chan, D. Weisenburger, W. Sanger, 1995, Blood.

LMO2 Expression And The Hans Algorithm In Predicting Germinal Center Phenotype And Survival In Diffuse Large B-cell Lymphoma Treated With Rituximab

L. Staudt, W. Chan, T. Greiner, 2009 .

Monoclonal antibodies marking T lymphocytes in paraffin-embedded tissue.

D. Weisenburger, J. Armitage, J. Linder, 1987, The American journal of pathology.

Counterflow centrifugation apheresis for the collection of autologous peripheral blood stem cells from patients with malignancies: A comparison with a standard centrifugation apheresis procedure

D. Weisenburger, J. Armitage, R. Wigton, 1990, Journal of clinical apheresis.

Bone Marrow Transplantation for Peripheral T-cel l Lymphoma in Children and Adolescents

Anderson, Julie, Phyllis, 2003 .

Peripheral T-cell lymphoma in children and adolescents: role of bone marrow transplantation.

D. Weisenburger, J. Armitage, W. Sanger, 1994, Leukemia & lymphoma.

Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents.

D. Weisenburger, J. Armitage, P. Bierman, 1992, Blood.

Peripheral T-Cell Lymphoma-A Brief Review.

D. Weisenburger, J. Armitage, P. Bierman, 1990, Leukemia & lymphoma.

Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

D. Weisenburger, C. Flowers, T. Habermann, 2014, Journal of the National Cancer Institute. Monographs.

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project.

D. Weisenburger, J. Armitage, J. Vose, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunoblastic lymphadenopathy associated with methyldopa therapy. A case report

D. Weisenburger, 1978, Cancer.

Lymphomas with follicular and monocytoid B-cell components. Evidence for a common clonal origin from follicle center cells.

B. Nathwani, T. Greiner, D. Weisenburger, 2000, American journal of clinical pathology.

Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings

D. Weisenburger, J. Armitage, W. Sanger, 1987 .

Hyperplasia of mantle/marginal zone B cells with clear cytoplasm in peripheral lymph nodes. A clinicopathologic study of 35 cases.

B. Nathwani, D. Weisenburger, R. Brynes, 2001, American journal of clinical pathology.

Immunoblastic lymphoma with abundant clear cytoplasm. A comparative study of B- and T-cell types.

D. Weisenburger, J. Armitage, H. Nakamine, 1991, American journal of clinical pathology.

Mantle zone lymphoma a clinicopathologic study of 22 cases

D. Weisenburger, J. Armitage, M. Bast, 1990, Cancer.

Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction.

J. Downing, D. Weisenburger, S. Shurtleff, 1995, Blood.

Sinus histiocytosis with massive lymphadenopathy: a spectrum of disease associated with immune dysfunction.

D. Weisenburger, H. Grierson, D. Maennle, 1991, Pediatric pathology.

The clinical spectrum of Castleman's disease

D. Weisenburger, J. Armitage, T. Habermann, 2012, American journal of hematology.

Castleman's disease of the leptomeninges. Report of three cases.

D. Weisenburger, R. Mccomb, B. Varet, 1988, Journal of neurosurgery.

Malignant lymphoma in Nebraska and Guangzhou, China: a comparative study.

D. Weisenburger, J. Armitage, M. Bast, 1987, Human pathology.

Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.

W. Chan, D. Weisenburger, J. Armitage, 1993, Leukemia & lymphoma.

Non-Hodgkin's lymphomas of mantle zone origin.

D. Weisenburger, J. Armitage, W. Sanger, 1991, Pathology annual.

B-cell neoplasia. A conceptual understanding based on the normal humoral immune response.

D. Weisenburger, J. Armitage, D. Harrington, 1990, Pathology annual.

T-cell-rich B-cell lymphoma. A clinicopathologic study of eight cases.

W. Chan, D. Weisenburger, N. Sun, 1995, American journal of clinical pathology.

Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.

D. Weisenburger, F. d'Amore, P. Johansen, 1996, Blood.

HTLV‐I Sequence in Lymphoproliferative Disorders

W. Chan, D. Weisenburger, Craig H. Hooper, 1993, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Systemic ALK-Positive Anaplastic Large-Cell Lymphoma (ALCL): Final Analysis of an International, Individual Patient Data Study of 263 Adults

D. Weisenburger, J. Armitage, J. Vose, 2017 .

CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECT

L. Staudt, A. Rosenwald, T. Greiner, 2021, Hematological Oncology.

Lymphomatoid Papulosis: A T-Cell Dyscrasia with a Propensity To Transform into Malignant Lymphoma

D. Weisenburger, F. Cabanillas, M. Duvic, 1995, Annals of Internal Medicine.

Lymphomatoid papulosis and progression to T cell lymphoma: an immunophenotypic and genotypic analysis.

D. Weisenburger, J. Armitage, W. Sanger, 1989, Journal of the American Academy of Dermatology.

Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma

Paolo Vineis, Theodore R Holford, Peter Kraft, 2014, Nature Genetics.

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes.

Paolo Vineis, Theodore R Holford, Peter Kraft, 2016, Human molecular genetics.

Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.

W. Chan, D. Weisenburger, J. Armitage, 1994, Seminars in hematology.

Cytogenetic abnormalities in B-immunoblastic lymphoma.

D. Weisenburger, J. Armitage, M. Bast, 1994, Leukemia & lymphoma.

Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue.

D. Weisenburger, J. Armitage, J. Linder, 1988, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Role of the herbicide atrazine in the development of non-Hodgkin's lymphoma.

D. Weisenburger, A. Blair, S. Zahm, 1993, Scandinavian journal of work, environment & health.

Remission of giant lymph node hyperplasia with anemia after radiotherapy

D. Weisenburger, J. Armitage, R. Degowin, 1979, Cancer.

Early leukemic recurrence of non-Hodgkin lymphoma after high-dose anti-neoplastic therapy with autologous marrow rescue.

D. Weisenburger, J. Armitage, W. Sanger, 1987, Bone marrow transplantation.

Cytogenetic abnormalities in noncutaneous peripheral T-cell lymphoma.

D. Weisenburger, J. Armitage, W. Sanger, 1986, Cancer genetics and cytogenetics.

Clinical Significance of the t(14;18) And BCL2 Overexpression in Follicular Large Cell Lymphoma

W. Chan, T. Greiner, D. Weisenburger, 2000, Leukemia & lymphoma.

Abnormalities involving chromosome 6 in newly diagnosed patients with non-Hodgkin's lymphoma. Nebraska Lymphoma Study Group.

D. Weisenburger, J. Armitage, W. Sanger, 1990, Cancer genetics and cytogenetics.

Polycomb response element-binding sites in the MDR of CLL: Potential tumor suppressor regulation

Christine E. Cutucache, D. Weisenburger, P. Bierman, 2013 .

PRE-binding sites in the MDR of CLL: Potential Tumor Suppressor Regulation

Christine E. Cutucache, D. Weisenburger, P. Bierman, 2013 .

Detection of the t(2;5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization.

D. Weisenburger, W. Sanger, D. Srivastava, 1997, Blood.

X-linked lymphoproliferative disease.

D. Weisenburger, T. Seemayer, S. Pirruccello, 1993, American journal of diseases of children.

Epstein-Barr virus--associated lymphoproliferative lesions.

D. Weisenburger, D. Purtilo, D. Harrington, 1988, Clinics in laboratory medicine.

Malignant lymphoma in the X‐linked lymphoproliferative syndrome

D. Weisenburger, D. Harrington, D. Purtilo, 1987, Cancer.

Chromosomal abnormalities in indolent lymphoma.

D. Weisenburger, J. Armitage, W. Sanger, 1987, Cancer genetics and cytogenetics.

A Pooled Analysis of Cigarette Smoking and Risk of Multiple Myeloma from the International Multiple Myeloma Consortium

D. Weisenburger, N. Camp, J. Spinelli, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Molecular Determinants of Lymph Node Microenvironment Induced Host Immune Tolerance In CLL: Role for CAV1, PTPN6, and PKCβ In the Process

D. Weisenburger, P. Bierman, R. Bociek, 2010 .

Molecular Basis of Proliferation/Survival and Migration of CLL in Peripheral Blood, Bone Marrow and Lymph Nodes

D. Weisenburger, R. Bociek, S. Joshi, 2008 .

Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin.

D. Weisenburger, S. Joshi, J. Verdirame, 1990, Leukemia research.

Expression of immune checkpoint molecules programmed death protein 1, programmed death‐ligand 1 and inducible T‐cell co‐stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcome

D. Weisenburger, Xiwei Wu, C. Querfeld, 2022, The British Journal of Dermatology.

Nerve growth factor receptor expression on dendritic reticulum cells in follicular lymphoid proliferations.

D. Weisenburger, H. Nakamine, R. Strobach, 1991, Human pathology.

Detection and clinical significance of minimal tumor cell contamination of peripheral stem call harvests

D. Weisenburger, S. Mann, A. Kessinger, 1992 .

Levels of detection of tumor cells in human bone marrow with or without prior culture.

D. Weisenburger, S. Joshi, J. Sharp, 1990, Bone Marrow Transplantation.

Immunophenotypic and genotypic characterization of lymphomatoid papulosis.

D. Weisenburger, H. Nakamine, W. Sanger, 1992, Journal of the American Academy of Dermatology.

Chromosomal abnormalities in patients with non-cutaneous T-cell non-Hodgkin's lymphoma. The Nebraska Lymphoma Study Group.

D. Weisenburger, J. Armitage, W. Sanger, 1990, European journal of cancer.

Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work).

L. Staudt, A. Rosenwald, W. Chan, 2004 .

Acute renal failure associated with autologous bone marrow transplantation.

D. Weisenburger, P. Bierman, J. Armitage, 1987, Bone marrow transplantation.

Clinical and pathologic analysis of extramedullary tumors after hematopoietic stem cell transplantation.

D. Weisenburger, P. Chu, D. Snyder, 2014, Human pathology.

Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells.

D. Weisenburger, J. Armitage, A. Kessinger, 1986, Experimental hematology.

Scientific category: Lymphoid neoplasia Title: Indolent T-cell lymphoproliferative disease of the gastrointestinal tract Authors:

D. Weisenburger, R. Warnke, C. Copie-Bergman, 2013 .

Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia.

D. Weisenburger, J. Armitage, A. Kessinger, 1989, Bone marrow transplantation.

Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.

D. Weisenburger, J. Armitage, W. Sanger, 1988, Cancer research.

Aggressive natural killer cell lymphoma of the small intestine.

T. Greiner, D. Weisenburger, D. Perry, 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells.

D. Weisenburger, D. Purtilo, R. Bashir, 1991, The American journal of pathology.

Non-Hodgkin lymphoma risk and organophosphate and carbamate insecticide use in the north American pooled project

D. Weisenburger, J. Spinelli, P. Albert, 2019, Environment international.

Serum Ig abnormalities in mantle cell lymphoma [7] (multiple letters)

D. Weisenburger, J. Armitage, G. Flandrin, 1997 .

Interstitial pneumonitis associated with azathioprine therapy.

D. Weisenburger, 1978, American journal of clinical pathology.

Acute myelofibrosis terminating as acute myeloblastic leukemia.

D. Weisenburger, 1980, American journal of clinical pathology.

Central Nervous System Involvement in Patients with Diffuse Aggressive Non‐Hodgkin's Lymphoma

D. Weisenburger, J. Armitage, P. Bierman, 1991, American journal of clinical oncology.

#461 Cytogenetic abnormalities in tumors from children with non-Hodgkinʼs lymphoma (NHL) or Hodgkinʼs disease (HD): Nebraska Lymphoma Study Group experience

D. Weisenburger, J. Armitage, M. Bast, 1999 .

Mantle-zone lymphoma: another opinion.

D. Weisenburger, 1986, The American journal of surgical pathology.

Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patients

D. Weisenburger, F. Hochberg, R. Bashir, 2005, Journal of Neuro-Oncology.

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro

T. Greiner, D. Weisenburger, J. Armitage, 2011, Leukemia.

Post‐transplant lymphoproliferative disorder: a heterogeneous conundrum

D. Weisenburger, T. Gross, T. G. Gross, 2017, British journal of haematology.

Oncogenically active MYD88 mutations in human lymphoma

Joseph M. Connors, Randy D. Gascoyne, Roland Schmitz, 2011, Nature.

Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project

B. Nathwani, D. Weisenburger, J. Armitage, 2016, Haematologica.

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project.

D. Weisenburger, J. Armitage, J. Vose, 2009, Blood.

Legionnaires' disease among pneumonias in Iowa (FY 1972–1978) II. Epidemiologic and clinical features of 30 sporadic cases of L. pneumophila infection

D. Weisenburger, C. Helms, L. Chiu, 1981, The American journal of the medical sciences.

Clonality analysis of B‐lymphoid proliferations using the polymerase chain reaction

W. C. Chan, T. Greiner, D. Weisenburger, 1996, Cancer.

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

B. Nathwani, D. Weisenburger, J. Armitage, 2011, Blood.

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.

W. Chan, T. Greiner, D. Weisenburger, 2010, Blood.

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

D. Weisenburger, J. Vose, Julie Vose, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.

B. Nathwani, D. Weisenburger, J. Armitage, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Systemic anaplastic large‐cell lymphoma: Results from the non‐Hodgkin's lymphoma classification project

B. Nathwani, D. Weisenburger, R. Gascoyne, 2001, American journal of hematology.

Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.

D. Weisenburger, J. Armitage, P. Bierman, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Peripheral T‐cell lymphoma: A clinicopathologic study of 42 cases

D. Weisenburger, J. Armitage, J. Linder, 1987, Hematological oncology.

Peripheral T‐cell lymphoma in childhood and adolescence a clinicopathologic study of 22 patients

D. Weisenburger, J. Armitage, J. Vose, 1993, Cancer.

Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.

T. Greiner, D. Weisenburger, J. Vose, 1999, Blood.

Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project.

D. Weisenburger, J. Armitage, James R. Anderson, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Relationship between ambient ultraviolet radiation and Hodgkin lymphoma subtypes in the United States

D. Weisenburger, R. Pfeiffer, M. Linet, 2016, British Journal of Cancer.

Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia.

D. Weisenburger, P. Babbitt, A. Blair, 1992, American journal of public health.

Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma

A Rosenwald, L. Staudt, A. Rosenwald, 2016, Leukemia.

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma

L. Staudt, A. Rosenwald, W. Chan, 2007, Leukemia.

The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma.

D. Weisenburger, B. Dave, Q. Lan, 2008, Journal of the National Cancer Institute. Monographs.

Fluorescence in situ Hybridization Detection of Cytogenetic Abnormalities in B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

D. Weisenburger, Lynette M. Smith, W. Sanger, 2004, Leukemia & lymphoma.

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.

L. Staudt, A. Rosenwald, W. Chan, 2012, Blood.

Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.

L. Staudt, A. Rosenwald, W. Chan, 2007, Blood.

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

D. Weisenburger, J. Cerhan, O. Nanni, 2014, Journal of the National Cancer Institute. Monographs.

Cell of origin fails to predict survival in patients with diffuse large B‐cell lymphoma treated with autologous hematopoietic stem cell transplantation

W. Chan, T. Greiner, D. Weisenburger, 2012, Hematological oncology.

HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.

D. Weisenburger, J. Cerhan, M. Carrington, 2018, Cancer research.

Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia

D. Weisenburger, M. Grever, J. Byrd, 2007, Cell.

Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis

D. Weisenburger, D. Richardson, R. Field, 2007, British journal of haematology.

MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma.

W. Chan, T. Greiner, D. Weisenburger, 2013, Blood.

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.

L. Staudt, A. Rosenwald, W. Chan, 2014, Blood.

Adult Burkitt lymphoma: advances in diagnosis and treatment.

W. Chan, D. Weisenburger, J. Armitage, 2008, Oncology.

Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma.

D. Weisenburger, J. Armitage, W. Sanger, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Deletion of cell division cycle 2-like 1 gene locus on 1p36 in non-Hodgkin lymphoma.

D. Weisenburger, J. Armitage, W. Sanger, 1999, Cancer genetics and cytogenetics.

Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization.

W. Chan, T. Greiner, D. Weisenburger, 2002, Cancer genetics and cytogenetics.

IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.

L. Staudt, A. Rosenwald, W. Chan, 2014, Blood.

p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis.

W. Chan, T. Greiner, D. Weisenburger, 1996, Blood.

Frequent occurrence of deletions in primary mediastinal B‐cell lymphoma

Jan Delabie, Randy D Gascoyne, Andreas Rosenwald, 2007, Genes, chromosomes & cancer.

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.

Michael R. Green, L. Staudt, A. Rosenwald, 2017, Blood.

The Genetic Basis of Hepatosplenic T-cell Lymphoma.

D. Dunson, I. Lossos, W. Chan, 2017, Cancer discovery.

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.

L. Staudt, A. Rosenwald, W. Chan, 2015, Blood.

Loss of signaling via Gα13 in germinal center B cell-derived lymphoma

Adrien B. Larsen, L. Staudt, A. Rosenwald, 2014, Nature.

Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.

W. Chan, D. Weisenburger, R. Warnke, 2013, Blood.

A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival.

W. Chan, T. Greiner, D. Weisenburger, 2003, Blood.

treatment outcome. The Nebraska Lymphoma Study Group lymphoma: associations with histology, clinical characteristics, and Chromosomal abnormalities in untreated patients with non-Hodgkin's

D. Weisenburger, J. Armitage, James R. Anderson, 2011 .

Basic References

Ash A. Alizadeh, R. Tibshirani, D. Botstein, 2022 .

Identification and functional relevance of de novo DNA methylation in cancerous B‐cell populations

W. C. Chan, T. Greiner, D. Weisenburger, 2010, Journal of cellular biochemistry.

Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics.

D. Weisenburger, J. Armitage, M. Bast, 1995, Cancer genetics and cytogenetics.

Lymphomas of follicles. Mantle cell and follicle center cell lymphomas.

D. Weisenburger, W. Chan, Wing C. Chan, 1993, American journal of clinical pathology.

Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group.

D. Weisenburger, J. Armitage, James R. Anderson, 1990, Blood.

Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group

W. Chan, T. Greiner, D. Weisenburger, 2000, American journal of hematology.

Mantle cell lymphoma-- an entity comes of age.

D. Weisenburger, J. Armitage, 1996, Blood.

Incidence of marginal zone lymphoma in the United States, 2001–2009 with a focus on primary anatomic site

D. Weisenburger, S. Devesa, L. Morton, 2014, British journal of haematology.

Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma

T. Greiner, D. Weisenburger, J. Vose, 2008, Molecular Cancer Therapeutics.

Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma

W. Chan, T. Greiner, D. Weisenburger, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Differences in incidence and trends of haematological malignancies in Japan and the United States

D. Weisenburger, K. Matsuo, Hidemi Ito, 2013, British journal of haematology.

Phenotype, genotype and clonality of Reed‐Sternberg cells in nodular sclerosis Hodgkin’s disease: results of a single‐cell study

W. Chan, D. Weisenburger, A. Tierens, 1996, British journal of haematology.

The antigen-presenting cell function of Reed-Sternberg cells.

W. Chan, D. Weisenburger, J. Delabie, 1995, Leukemia & lymphoma.

Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.

D. Weisenburger, J. Armitage, P. Bierman, 1991, The American journal of medicine.

Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up.

D. Weisenburger, J. Armitage, P. Bierman, 1992, Blood.

Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines

D. Weisenburger, A. Scuto, V. Ngo, 2017, Leukemia & lymphoma.

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project.

D. Weisenburger, J. Armitage, J O Armitage, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mantle‐zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma

D. Weisenburger, H. Rappaport, Hun Kim, 1982, Cancer.

Malignant lymphoma, intermediate lymphocytic type: A clinicopathologic study of 42 cases

B. Nathwani, D. Weisenburger, L. Diamond, 1981, Cancer.

The relationship between lymphocyte nuclear morphology and cell cycle stage in lymphoid neoplasia

D. Weisenburger, L. Diamond, H. Rappaport, 1981, American journal of hematology.

Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms.

L. Staudt, A. Rosenwald, W. Chan, 2014, Cancer discovery.

Epstein-Barr Virus Negative Clonal Plasma Cell Proliferations and Lymphomas in Peripheral T-cell Lymphomas: A Phenomenon With Distinctive Clinicopathologic Features

D. Weisenburger, R. Warnke, K. Fu, 2007, The American journal of surgical pathology.

Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries

D. Weisenburger, J. Vose, N. Schmitz, 2003, British journal of haematology.

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy

L. Staudt, A. Rosenwald, W. Chan, 2011, Haematologica.

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.

L. Staudt, A. Rosenwald, W. Chan, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

L. Staudt, A. Rosenwald, W. Chan, 2019, Blood.

Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases.

B. Nathwani, D. Weisenburger, J. Armitage, 2012, Blood.

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

Stefano A Pileri, Lisa Rimsza, Randy D Gascoyne, 2008, Blood.

Proliferative fraction and DNA content are lower in B-cell non-Hodgkin's lymphomas with the t(14;18).

D. Weisenburger, J. Armitage, M. Bast, 1995, Leukemia & lymphoma.

germinal center B-cell gene expression profile The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a

Ash A. Alizadeh, L. Staudt, I. Lossos, 2013 .

The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile.

Ash A. Alizadeh, Ash A Alizadeh, Timothy C Greiner, 2002, Blood.

BCL 2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

L. Staudt, A. Rosenwald, W. Chan, 2016 .

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

L. Staudt, A. Rosenwald, W. Chan, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay.

W. Chan, D. Weisenburger, J. Delabie, 1994, Blood.

Intermediate lymphocytic lymphoma: an immunohistologic study with comparison to other lymphocytic lymphomas.

D. Weisenburger, J. Armitage, J. Linder, 1987, Human pathology.

Initial and subsequent cytogenetic studies in malignant lymphoma

D. Weisenburger, J. Armitage, W. Sanger, 1987, Cancer.

A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

Kai Fu, Javeed Iqbal, Jan Delabie, 2009, Clinical Cancer Research.

Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma.

W. Chan, D. Weisenburger, V. Bedell, 2021, Human pathology.

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

D. Weisenburger, P. Hartge, S. Devesa, 2006, Blood.

Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipients

D. Weisenburger, C. Lynch, E. Engels, 2014, Haematologica.

Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma

L. Staudt, A. Rosenwald, W. Chan, 2006, Proceedings of the National Academy of Sciences of the United States of America.

A Review and Update with Perspective of Evidence that the Herbicide Glyphosate (Roundup) is a Cause of Non-Hodgkin Lymphoma.

D. Weisenburger, 2021, Clinical lymphoma, myeloma & leukemia.

Racial patterns of extranodal natural killer/T‐cell lymphoma, nasal type, in California: a population‐based study

D. Weisenburger, K. Fu, E. Chang, 2012, British journal of haematology.

A Case‐Control Study of Non‐Hodgkin's Lymphoma and the Herbicide 2,4‐Dichlorophenoxyacetic Acid (2, 4‐D) in Eastern Nebraska

D. Weisenburger, P. Babbitt, A. Blair, 1990, Epidemiology.

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling.

L. Staudt, A. Rosenwald, W. Chan, 2012, Blood.

Cutaneous &ggr;&dgr; T-cell Lymphomas: A Spectrum of Presentations With Overlap With Other Cytotoxic Lymphomas

D. Weisenburger, G. Wood, D. Ivan, 2012, The American journal of surgical pathology.

Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium

D. Weisenburger, J. Cerhan, N. Rothman, 2012, Cancer Causes & Control.

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies.

L. Staudt, A. Rosenwald, W. Chan, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic Lymphocytic Leukemia Cells in a Lymph Node Microenvironment Depict Molecular Signature Associated with an Aggressive Disease

D. Weisenburger, S. Joshi, R. Opavsky, 2014, Molecular medicine.

CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma

Michael L. Wang, D. Weisenburger, G. Marcucci, 2016, Oncotarget.

Association of NAT and GST polymorphisms with non‐Hodgkin's lymphoma: a population‐based case–control study

D. Weisenburger, James R. Anderson, S. Gapstur, 2005, British journal of haematology.

Diet and risk of adult glioma in eastern Nebraska, United States

D. Weisenburger, B. Graubard, K. Tucker, 2002, Cancer Causes & Control.

Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy.

D. Weisenburger, J. Armitage, R. Wigton, 1991, Bone marrow transplantation.

Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique.

D. Weisenburger, J. Sharp, S. Joshi, 1992, Blood.

survival in mantle cell lymphoma mRNAs that are associated with increased proliferation rate and shorter Point mutations and genomic deletions in Cyclin D1 create stable truncated

L. Staudt, A. Rosenwald, W. Chan, 2013 .

Is a duplication of 14q32 a new recurrent chromosomal alteration in B-cell non-Hodgkin lymphoma?

D. Weisenburger, J. Armitage, W. Sanger, 1999, Cancer genetics and cytogenetics.

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma.

D. Torrents, A. Rosenwald, D. Weisenburger, 2019, Blood.

Inmunoglobulin light chain enhancer hijacking activates CCND2 and CCND3 in cyclin D1-negative mantle cell lymphoma

Miriam, Renata, D. Torrents, 2018 .

Epidemiology and Pathology of T- and NK-Cell Lymphomas.

D. Weisenburger, J. Song, P. Siaghani, 2018, Cancer treatment and research.

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

L. Staudt, A. Rosenwald, W. Chan, 2006, Blood.

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

L. Staudt, A. Rosenwald, W. Chan, 2006, Blood.

Lymphoma Epidemiology Consortium (InterLymph) research from the Pathology Working Group of the International Proposed classification of lymphoid neoplasms for epidemiologic

D. Weisenburger, J. Cerhan, J. Spinelli, 2011 .

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).

D. Weisenburger, J. Cerhan, J. Spinelli, 2007, Blood.

InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.

Adele Seniori Costantini, James R Cerhan, D. Weisenburger, 2010, Blood.

Vaccination history and risk of non-hodgkin lymphoma: a population-based, case–control study

D. Weisenburger, A. Evens, H. Lankes, 2009, Cancer Causes & Control.

Non‐Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non‐Hodgkin Lymphoma Classification Project

B. Nathwani, D. Weisenburger, J. Armitage, 2016, British journal of haematology.

Adenocarcinoma of the Stomach and Esophagus and Drinking Water and Dietary Sources of Nitrate and Nitrite

D. Weisenburger, M. Ward, R. Markin, 2008, International journal of occupational and environmental health.

Anaplastic large cell lymphoma in human immunodeficiency virus‐infected people and solid organ transplant recipients

D. Weisenburger, A. Kahn, E. Engels, 2020, British journal of haematology.

Characteristics and outcomes of diffuse large B‐cell lymphoma presenting in leukaemic phase

D. Weisenburger, J. Armitage, M. Bast, 2012, British journal of haematology.

Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic.

D. Weisenburger, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Cyclin D1 expression in peripheral T-cell lymphomas

B. Nathwani, D. Weisenburger, A. Feldman, 2016, Modern Pathology.

Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.

B. Nathwani, D. Weisenburger, J. Armitage, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical significance of follicular lymphoma with monocytoid B cells. Non-Hodgkin's Lymphoma Classification Project.

B. Nathwani, D. Weisenburger, J. Armitage, 1999, Human pathology.

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.

Kai Fu, Jan Delabie, Randy D Gascoyne, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

L. Staudt, A. Rosenwald, W. Chan, 2005, Blood.

Chapter 4 Molecular Diagnosis of Burkitt lymphoma

Armitage, L. Staudt, A. Rosenwald, 2019 .

Pitfalls and major issues in the histologic diagnosis of peripheral T‐cell lymphomas: results of the central review of 573 cases from the T‐Cell Project, an international, cooperative study

D. Weisenburger, J. Vose, S. Pileri, 2017, Hematological oncology.

Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project

B. Nathwani, D. Weisenburger, J. Armitage, 2015, Annals of Hematology.

DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status

T. Wolfsberg, W. C. Chan, W. Chan, 2008, Leukemia.

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.

L. Staudt, A. Rosenwald, W. Chan, 2012, Blood.

Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM.

D. Weisenburger, M. Pfreundschuh, L. Trümper, 2011, Blood.

Projeto de célula-T: estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivo

D. Weisenburger, J. Vose, S. Montoto, 2009 .

Mantle‐zone lymphoma. An immunohistologic study

D. Weisenburger, D D Weisenburger, 1984, Cancer.

Phenotypic heterogeneity in multiple myeloma families.

D. Weisenburger, O. Olopade, W. Sanger, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens.

L. Staudt, A. Rosenwald, W. Chan, 2018, Blood.

Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.

D. Weisenburger, J. Armitage, P. Bierman, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.

L. Staudt, A. Rosenwald, W. Chan, 2010, Blood.

Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.

B. Nathwani, D. Weisenburger, J. Armitage, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro

T. Greiner, D. Weisenburger, J. Armitage, 2011, Leukemia.

BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma.

L. Staudt, A. Rosenwald, W. Chan, 2014, Human pathology.

Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP.

L. Staudt, A. Rosenwald, W. Chan, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.

A. Rosenwald, W. Chan, D. Weisenburger, 2013, American journal of clinical pathology.

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma.

L. Staudt, A. Rosenwald, W. Chan, 2012, Blood.

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma.

L. Staudt, A. Rosenwald, W. Chan, 2007, Blood.

Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma

W. Chan, T. Greiner, D. Weisenburger, 2005, Modern Pathology.

Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18.

D. Weisenburger, C. Reynolds, N. Harris, 1999, Cancer research.

Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline‐Based Therapy

W. Chan, T. Greiner, D. Weisenburger, 2017, Clinical lymphoma, myeloma & leukemia.

Prognostic value of cellular proliferation and histologic grade in follicular lymphoma.

W. Chan, D. Weisenburger, J. Armitage, 1995, Blood.

Dietary patterns and the risk of non-Hodgkin lymphoma

D. Weisenburger, Sonali M. Smith, N. Ollberding, 2013, Public Health Nutrition.

Meat intake and risk of non-Hodgkin lymphoma

D. Weisenburger, Sonali M. Smith, N. Ollberding, 2012, Cancer Causes & Control.

Dietary intake of fruit and vegetables and risk of non-Hodgkin lymphoma

D. Weisenburger, Sonali M. Smith, A. Evens, 2011, Cancer Causes & Control.

Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status

D. Weisenburger, B. Dave, S. Joshi, 2016, Leukemia & lymphoma.

t(14;18)-negative Follicular Lymphomas Are Associated with a High Frequency of BCL6 Rearrangement at the Alternative Breakpoint Region

Kai Fu, Javeed Iqbal, Patricia Aoun, 2009, Modern Pathology.

Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphoma

D. Weisenburger, S. Bullman, J. Boland, 2021, Infectious Agents and Cancer.

Autologous hematopoietic stem cell transplantation for mantle cell lymphoma.

W. Chan, T. Greiner, D. Weisenburger, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma.

W. Chan, D. Weisenburger, L. Kwak, 2019, Blood.

Clonality in nodular lymphocyte-predominant Hodgkin's disease.

W. Chan, D. Weisenburger, S. Hinrichs, 1997, The New England journal of medicine.

Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).

D. Weisenburger, J. Cerhan, P. Vineis, 2006, Blood.

Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen.

Charles Enke, W. Chan, T. Greiner, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.

D. Weisenburger, J. Armitage, P. Bierman, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group.

W. Chan, T. Greiner, D. Weisenburger, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors influencing survival in patients with B‐cell small lymphocytic lymphoma

D. Weisenburger, J. Armitage, Lynette M. Smith, 2004, American journal of hematology/oncology.

Matrigel modulates a stem cell phenotype and promotes tumor formation in a mantle cell lymphoma cell line

D. Weisenburger, J. Sharp, T. McGuire, 2013 .

AccuracyLymphoma into Molecular Subtypes with High A New Immunostain Algorithm Classifies Diffuse Large

T. Greiner, D. Weisenburger, 2009 .

Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt’s lymphoma

L. Staudt, A. Rosenwald, W. Chan, 2008, Haematologica.

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

D. Weisenburger, S. Lade, C. McCarthy, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.

D. Weisenburger, J. Armitage, L. Klassen, 1989, Bone marrow transplantation.

Implant-associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules.

D. Weisenburger, A. Nademanee, Wengang Chen, 2013, Clinical breast cancer.

Marginal Z one B -Cell L ymphoma: A C linical C omparison of N odal a nd M ucosa-Associate d L ymphoid T issue T ypes

B. Nathwani, D. Weisenburger, J. Armitage, 1999 .

Breast implants and anaplastic large cell lymphomas among females in the California Teachers Study cohort

D. Weisenburger, L. Bernstein, D. Deapen, 2016, British journal of haematology.

Relationship between Rosai-Dorfman disease and IgG4-related disease: study of 32 cases.

D. Weisenburger, K. Fu, Lynette M. Smith, 2013, American journal of clinical pathology.

Immunohistochemical and molecular cytogenetic evaluation of potential targets for tyrosine kinase inhibitors in Langerhans cell histiocytosis.

T. Greiner, D. Weisenburger, W. Sanger, 2012, Human pathology.

Hairy cell leukaemia: a heterogeneous disease?

D. Weisenburger, P. Rosenberg, R. Matsuno, 2008, British journal of haematology.

Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. The Non-Hodgkin's Lymphoma Classification Project.

Anderson, B. Nathwani, W. Chan, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.

D. Weisenburger, P. Bierman, J. Vose, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic counseling for DAPK1 mutation in a chronic lymphocytic leukemia family.

D. Weisenburger, W. Sanger, H. Lynch, 2008, Cancer genetics and cytogenetics.

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.

W. Chan, D. Weisenburger, A. LaCasce, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma.

D. Weisenburger, J. Armitage, M. Bast, 1990, Cancer research.

Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?

D. Weisenburger, E. Chang, S. Glaser, 2015, Cancer Epidemiology, Biomarkers & Prevention.

The therapy of non-Hodgkin's lymphomas. Introduction and overview.

D. Weisenburger, J. Armitage, P. Bierman, 1991, Hematology/Oncology Clinics of North America.

Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma.

W. Chan, D. Weisenburger, J. Armitage, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience.

D. Weisenburger, J. Armitage, Lynette M. Smith, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Diffuse intermediate lymphocytic lymphoma. A clinicopathologic study and comparison with small lymphocytic lymphoma and diffuse small cleaved cell lymphoma

D. Weisenburger, J. Armitage, M. Bast, 1990, Cancer.

Towards understanding the peripheral T-cell lymphomas.

D. Weisenburger, J. Armitage, J. Vose, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Trial of high-dose cytarabine, cyclophosphamide, total-body irradiation, and autologous marrow transplantation for refractory lymphoma.

D. Weisenburger, P. Bierman, L. Klassen, 1986, Cancer treatment reports.

Detection of malignant cells in histologically normal bone marrow using culture techniques.

D. Weisenburger, S. Joshi, S. Mann, 1987, Bone marrow transplantation.

Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage.

W. Chan, T. Greiner, D. Weisenburger, 1995, Blood.

Late relapse in patients with diffuse large B‐cell lymphoma

D. Weisenburger, J. Armitage, P. Bierman, 2010, British journal of haematology.

MUTATIONS IN AITL 1 IDH 2 R 172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

L. Staudt, A. Rosenwald, W. Chan, 2015 .

Extranodal natural killer/T-cell lymphoma with paraneoplastic eosinophilic myositis

D. Weisenburger, J. Zain, J. Mallick, 2020 .

Histologic grade does not predict prognosis in optimally treated, advanced‐stage nodular sclerosing Hodgkin's disease

D. Weisenburger, J. Armitage, J. Vose, 1992, Cancer.

Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma.

W. Chan, T. Greiner, D. Weisenburger, 1996, Blood.

Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status

D. Weisenburger, G. Marcucci, I. Aldoss, 2017, Haematologica.

Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma.

W. Chan, T. Greiner, D. Weisenburger, 1998, Journal of Clinical Oncology.

Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study.

D. Weisenburger, J. Armitage, P. Bierman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

B‐cell lymphoma, unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and burkitt lymphoma: study of 39 cases

W. Chan, T. Greiner, D. Weisenburger, 2013, British journal of haematology.

ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients

A. Rosenwald, D. Weisenburger, J. Armitage, 2019, Haematologica.

Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists

B. Nathwani, D. Weisenburger, J. Armitage, 2012, Leukemia & lymphoma.

Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system

B. Nathwani, D. Weisenburger, J. Armitage, 2011, Leukemia & lymphoma.

Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification

B. Nathwani, D. Weisenburger, J. Armitage, 2015, Leukemia & lymphoma.

Primary Cutaneous Gamma-Delta T-Cell Lymphoma Mimicking anaplastic lymphoma kinase-1-Negative Anaplastic Large Cell Lymphoma: A Case Report

D. Weisenburger, M. Ulrickson, J. Song, 2021, The American Journal of dermatopathology.

Nutrient Intakes and Adenocarcinoma of the Esophagus and Distal Stomach

D. Weisenburger, B. Graubard, R. Russell, 2002, Nutrition and cancer.

Effect of catechol and ethanol with and without methylamylnitrosamine on esophageal carcinogenesis in the rat.

D. Weisenburger, S. Hinrichs, S. Mirvish, 1994, Carcinogenesis.

Drinking Water Nitrate and the Risk of Non‐Hodgkin's Lymphoma

D. Weisenburger, M. Ward, S. Zahm, 1996, Epidemiology.

Carcinogenicity tests of methyl-n-amylnitrosamine (MNAN) administered to newborn and adult rats and hamsters and adult mice and of 2-oxo-MNAN administered to adult rats.

D. Weisenburger, T. Smyrk, S. Mirvish, 1996, Cancer letters.

IARC Monographs: 40 Years of Evaluating Carcinogenic Hazards to Humans

A. Baccarelli, F. Perera, D. Weisenburger, 2015, Environmental health perspectives.

Insecticide use and risk of non‐Hodgkin lymphoma subtypes: A subset meta‐analysis of the North American Pooled Project

D. Weisenburger, J. Spinelli, P. Demers, 2020, International Journal of Cancer.

Risk factors for non‐Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population‐based case‐control study

D. Weisenburger, J. Cerhan, N. Rothman, 2011, International journal of cancer.

BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab

L. Staudt, A. Rosenwald, W. Chan, 2011, Clinical Cancer Research.

RESPONSE: Re: Familial Multiple Myeloma: a Family Study and Review of the Literature

D. Weisenburger, W. Sanger, H. Lynch, 2002 .

Occupation and Risk of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia

D. Weisenburger, A. Blair, S. Zahm, 2002, Journal of occupational and environmental medicine.

Classification of Hodgkin and non-Hodgkin lymphoma

D. Weisenburger, J. Song, 2017 .

Brief report Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent ﬁnding in familial and sporadic MGUS/MM

D. Weisenburger, L. Trümper, H. Lynch, 2011 .

Sun exposure and non-Hodgkin lymphoma: a population-based, case-control study.

L. Hou, D. Weisenburger, S. Gapstur, 2007, European journal of cancer.

Obesity and risk of non-Hodgkin lymphoma (United States)

D. Weisenburger, S. Gapstur, A. Evens, 2007, Cancer Causes & Control.

MYC and BCL2 protein expression predicts survival in patients with diffuse large B‐cell lymphoma treated with rituximab

W. Chan, T. Greiner, D. Weisenburger, 2014, British journal of haematology.

The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab.

Kai Fu, Jan Delabie, Andreas Rosenwald, 2011, American journal of clinical pathology.

Scientific category : LYMPHOID NEOPLASIA Title : A new biological prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

L. Staudt, A. Rosenwald, W. Chan, 2012 .

Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.

L. Staudt, I. Lossos, D. Weisenburger, 2011, International journal of molecular epidemiology and genetics.

Original Article Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemi- ologic study in the pre-rituximab era

L. Staudt, I. Lossos, D. Weisenburger, 2011 .

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

L. Staudt, A. Rosenwald, J. Powell, 2007 .

lymphoma by immunohistochemistry using a tissue microarray Confirmation of the molecular classification of diffuse large B-cell

L. Staudt, A. Rosenwald, T. Greiner, 2013 .

Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraf fi n-Embedded Biopsies

L. Staudt, A. Rosenwald, W. Chan, 2017 .

Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma.

W. Chan, D. Weisenburger, A. Nademanee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome

W. Chan, T. Greiner, D. Weisenburger, 2015, Leukemia & lymphoma.

Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma.

B. Nathwani, W. Chan, T. Greiner, 2018, Human pathology.

Does a diffuse growth pattern predict for survival in patients with low-grade follicular lymphoma?

D. Weisenburger, J. Vose, M. Bast, 2009, Leukemia & lymphoma.

Physical activity and the risk of non‐Hodgkin lymphoma subtypes: A pooled analysis

Dennis P. Robinson, D. Weisenburger, J. Cerhan, 2022, International journal of cancer.

Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project.

Jennifer Kelly, Joshua N Sampson, Wendy Cozen, 2014, Journal of the National Cancer Institute. Monographs.

Non‐Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph Consortium

D. Weisenburger, J. Cerhan, P. Hartge, 2007, International journal of cancer.

Validation of the double-hit gene expression signature (DLBCL90) in an independent cohort of patients with diffuse large B-cell lymphoma of germinal center origin.

W. Chan, D. Weisenburger, D. Scott, 2021, The Journal of molecular diagnostics : JMD.

Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status

L. Staudt, A. Rosenwald, W. Chan, 2016, Leukemia & lymphoma.

Pesticide use and risk of Hodgkin lymphoma: results from the North American Pooled Project (NAPP)

D. Weisenburger, J. Spinelli, P. Demers, 2020, Cancer Causes & Control.

The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component

D. Weisenburger, J. Armitage, P. Bierman, 2009, British journal of haematology.

Systemic polyclonal B-immunoblastic proliferation with marked peripheral blood and bone marrow plasmacytosis.

D. Weisenburger, G. Soori, E. Poje, 1992, American journal of clinical pathology.

Thrombotic thrombocytopenic purpura with C'3 vascular deposits: report of a case.

D. Weisenburger, M. Hart, M. O'conner, 1977, American journal of clinical pathology.

Alcohol consumption, family history of hematolymphoproliferative cancer, and the risk of non-Hodgkin's lymphoma in men.

D. Weisenburger, L. Burmeister, A. Blair, 2002, Annals of epidemiology.

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

L. Staudt, A. Rosenwald, W. Chan, 2015, The American journal of surgical pathology.

Dietary nitrate and nitrite intake and risk of non-Hodgkin lymphoma

D. Weisenburger, Sonali M. Smith, B. Dave, 2013, Leukemia & lymphoma.

Non-Hodgkin's lymphoma and nitrate in drinking water

D. Weisenburger, M. Ward, S. Mark, 2000, Journal of Epidemiology and Community Health.

D. Weisenburger, Xiwei Wu, C. Querfeld, 2022, The British journal of dermatology.

Carcinogenicity of 1-(2-hydroxyethyl)-1-nitrosourea and 3-nitroso-2-oxazolidinone administered in drinking water to male MRC-Wistar rats: induction of bone, hematopoietic, intestinal, and liver tumors.

D. Weisenburger, S. Mirvish, S. Salmasi, 1987, Journal of the National Cancer Institute.

Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma

Youli Zu, Jan Delabie, Randy D Gascoyne, 2005, Leukemia & lymphoma.

University of Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

Waldmann, Meili, L. Staudt, 2012 .

Agricultural pesticide use and risk of glioma in Nebraska, United States

D. Weisenburger, M. Ward, J. Colt, 2005, Occupational and Environmental Medicine.

Safety and efficacy of YM155 in diffuse large B-cell lymphoma (DLBCL).

D. Weisenburger, J. Vose, B. Cheson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patients with Follicular Lymphoma, Grade 3, Have a Prolonged Relapse-Free Survival Following Aggressive Combination Chemotherapy.

D. Weisenburger, J. Armitage, Lynette M. Smith, 2004 .

Dietary intake of fruits and vegetables and overall survival in non-Hodgkin lymphoma

D. Weisenburger, Sonali M. Smith, N. Ollberding, 2013, Leukemia & lymphoma.

Epstein–Barr virus and Hodgkin’s lymphoma in Cairo, Egypt

B. Nathwani, D. Weisenburger, J. Armitage, 2010, Journal of hematopathology.

Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma.

D. Weisenburger, S. Gapstur, L. Burmeister, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Pesticide exposures and the risk of multiple myeloma in men: An analysis of the North American Pooled Project

D. Weisenburger, J. Spinelli, A. Blair, 2016, International journal of cancer.

Sex differences in the risk of multiple myeloma associated with agriculture.

D. Weisenburger, A. Blair, S. Zahm, 1992, British journal of industrial medicine.

Multicentric Angiofollicular Lymph Node Hyperplasia: Pathology of the Spleen

D. Weisenburger, 1988, The American journal of surgical pathology.

CD28 Mutations in Peripheral T-Cell Lymphomagenesis and Progression

L. Staudt, A. Rosenwald, W. Chan, 2014 .

Pesticide use and risk of Hodgkin lymphoma: results from the North American Pooled Project (NAPP)

D. Weisenburger, J. Spinelli, P. Demers, 2020, Cancer Causes & Control.

Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults

D. Weisenburger, G. Venkataraman, A. Duffield, 2016, Leukemia & lymphoma.

Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways

L. Staudt, A. Rosenwald, W. Chan, 2016 .

Lymphdx: A Custom Microarray for Molecular Diagnosis and Prognosis in Non-Hodgkin Lymphoma.

L. Staudt, A. Rosenwald, J. Powell, 2004 .

Cytogenetic abnormalities and clinical correlations in peripheral T‐cell lymphoma

D. Weisenburger, J. Armitage, R. Gascoyne, 2008, British journal of haematology.

Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphoma

D. Weisenburger, S. Bullman, J. Boland, 2021, Infectious agents and cancer.

Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care

Kai Fu, Patricia Aoun, Timothy C Greiner, 2014, British journal of haematology.

Chemical exposures and risk of chronic lymphocytic leukaemia

D. Weisenburger, A. Blair, M. Purdue, 2007, British journal of haematology.

Genome‐wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features

L. Staudt, A. Rosenwald, W. Chan, 2013, International journal of cancer.

The prognostic significance of lymphopenia in peripheral T‐cell and natural killer/T‐cell lymphomas: A study of 826 cases from the International Peripheral T‐cell Lymphoma Project

D. Weisenburger, J. Armitage, J. Vose, 2012, American journal of hematology.

Sporadic Legionnaires' Disease: Clinical Observations on 87 Nosocomial and Community‐Acquired Cases

D. Weisenburger, C. Helms, L. Chiu, 1984, The American journal of the medical sciences.

Four Lymphomas in 1 Patient: A Unique Case of Triple Composite Non-Hodgkin Lymphoma Followed by Classical Hodgkin Lymphoma

D. Weisenburger, M. Nasr, D. Sekiguchi, 2017, International Journal of Surgical Pathology.

Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?

D. Weisenburger, J. Armitage, P. Bierman, 2013, Clinical lymphoma, myeloma & leukemia.

Multicentric Castleman's disease in a child with prominent thymic involvement: a case report and brief review of the literature.

D. Weisenburger, V. Joshi, C. T. Holbrook, 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Malakoplakia of bone. An unusual cause of pathologic fracture in an immunosuppressed patient.

D. Weisenburger, T. Vinh, B. Levinson, 1985, Clinical orthopaedics and related research.

Legionnaires' disease.

D. Weisenburger, E. Renner, H. Rappaport, 1980, The American journal of medicine.

Pre‐diagnosis cigarette smoking and overall survival in non‐Hodgkin lymphoma

D. Weisenburger, Sonali M. Smith, A. Evens, 2013, British journal of haematology.

Peripheral T-cell lymphoma, not otherwise speciﬁed: a report of 340 cases from the International Peripheral T-cell Lymphoma Project

B. Nathwani, D. Weisenburger, J. Armitage, 2022 .

Lymph node‐induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin‐1

D. Weisenburger, P. Bierman, S. Joshi, 2012, British journal of haematology.

Double Expressing (MYC/BCL2) and Double-Hit Diffuse Large B-Cell Lymphomas Have Inferior Survival Following Autologous Stem Cell Transplantation

D. Weisenburger, A. LaCasce, A. Nademanee, 2015 .

Structural profiles of TP 53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma : an international collaborative study

L. Staudt, A. Rosenwald, W. Chan, 2008 .

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Meland, L. Staudt, A. Rosenwald, 2002, The New England journal of medicine.

DigitalCommons@UNO DigitalCommons@UNO

D. Weisenburger, S. Joshi, R. Opavsky, 2022 .

The BCL6‐associated transcriptional co‐repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation

W. Chan, D. Weisenburger, K. Fu, 2007, The Journal of pathology.

DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T-cells in PTCL-NOS.

Tyler A. Herek, L. Staudt, A. Rosenwald, 2022, Blood.

lineage disease and concurrent or subsequent large-cell lymphoma of B Clonal relationship between lymphocytic predominance Hodgkin's

T. Greiner, D. Weisenburger, A. Tierens, 2011 .

N-nitrosoatrazine : synthesis, kinetics of formation, and nuclear magnetic resonance spectra and other properties

Peter M. Gannett, D. Weisenburger, P. Gannett, 1991 .

Stromal Tumor Microenvironment in Chronic Lymphocytic Stromal Tumor Microenvironment in Chronic Lymphocytic Leukemia: Regulation of Leukemic Progression Leukemia: Regulation of Leukemic Progression

Christine E. Cutucache, D. Weisenburger, P. Bierman, 2022 .

Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome.

D. Weisenburger, D. Purtilo, R. Markin, 1987, Archives of pathology & laboratory medicine.

High prevalence of viral hepatitis in a series of splenic marginal zone lymphomas from Romania

D. Weisenburger, M. Blaga, A. Irimie, 2016, Blood Cancer Journal.

Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma

W. Chan, D. Weisenburger, David Steven Scott, 2023, Haematologica.

THE MUTATIONAL LANDSCAPE OF DOUBLE/TRIPLE‐HIT HIGH‐GRADE B‐CELL LYMPHOMA WITH BCL2 REARRANGEMENT (DH/TH‐ BCL2 ) – AN LLMPP PROJECT

L. Staudt, A. Rosenwald, T. Greiner, 2021, Hematological Oncology.

Potential Pathogenetic Role of Achromobacter (Alcaligenes) Xylosoxidans in Primary Extranodal Marginal Zone Lymphoma of the Lung (BALT-Lymphoma): Update of the Results of a Retrospective Analysis on Behalf of IELSG

D. Weisenburger, J. Armitage, F. Cavalli, 2011 .

MALT) Lymphoma Lie within or near the Previously Undescribed Gene MALT1 in Chromosome 18 1

D. Weisenburger, C. Reynolds, N. Harris, 1999 .

Peripheral T‐cell lymphoma

B. Nathwani, D. Weisenburger, J. Armitage, 1989, Cancer.

Clinical Trials and Observations

L. Staudt, A. Rosenwald, W. Chan, 2007 .

Structural profiles of TP 53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma : an international collaborative study

L. Staudt, A. Rosenwald, W. Chan, 2008 .

severe combined immunodeficiency caused by complete deficiency of the CD 3 subunit of the T-cell antigen receptor complex

L. Staudt, A. Rosenwald, W. Chan, 2007 .

Specificity of Leu-M1 antibody for Reed-Sternberg cells.

D. Weisenburger, P. Bierman, 1985, American journal of clinical pathology.

Responses to second-line tyrosine kinase inhibitors are durable: an intention-to-treat analysis in chronic myeloid leukemia patients.

L. Staudt, A. Rosenwald, T. Greiner, 2012, Blood.

Clinical Trials and Observations

C. Bloomfield, L. Staudt, A. Rosenwald, 2005 .

Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1.

D. Weisenburger, R. Brynes, Wengang Chen, 2013, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS

D. Weisenburger, J. Cerhan, C. Flowers, 2022, Cancer Epidemiology, Biomarkers and Prevention.

LYMPHOID NEOPLASIA IDH2 R172 mutations de ﬁ ne a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

L. Staudt, T. Greiner, D. Weisenburger, 2015 .

Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms.

L. Staudt, A. Rosenwald, W. Chan, 2014, Cancer discovery.

IARC Monographs: 40 Years of Evaluating Carcinogenic Hazards to Humans

A. Baccarelli, F. Perera, D. Weisenburger, 2015, Environmental health perspectives.

The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile.

Ash A. Alizadeh, L. Staudt, I. Lossos, 2002, Blood.

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: fin

L. Staudt, D. Weisenburger, J. Vose, 2007 .

D. Weisenburger, J. Armitage, J. Vose, 2008, Blood.

Clinical Trials and Observations

L. Staudt, T. Greiner, D. Weisenburger, 2008 .

Pesticide exposures and the risk of multiple myeloma in men: An analysis of the North American Pooled Project

D. Weisenburger, J. Spinelli, A. Blair, 2016, International journal of cancer.

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.

L. Staudt, A. Rosenwald, W. Chan, 2010, Blood.

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.

L. Staudt, A. Rosenwald, W. Chan, 2012, Blood.

Adult Burkitt lymphoma: advances in diagnosis and treatment.

W. Chan, D. Weisenburger, J. Armitage, 2008, Oncology.

Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium

T. Greiner, D. Weisenburger, R. Advani, 2023, Journal of Hematology & Oncology.

Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Clinicopathologic Study of 340 Cases from the International T-Cell Lymphoma Project.

D. Weisenburger, J. Vose, W. Wilson, 2006 .

Late relapse in patients with diffuse large B‐cell lymphoma

D. Weisenburger, J. Armitage, P. Bierman, 2010, British journal of haematology.

Cytogenetic abnormalities and clinical correlations in peripheral T‐cell lymphoma

D. Weisenburger, J. Armitage, R. Gascoyne, 2008, British journal of haematology.

Non‐Hodgkin lymphoma of the prostate

D. Weisenburger, P. Bierman, J. Vose, 2011, American journal of hematology.

Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma

W. Chan, D. Weisenburger, J. Niland, 2019, Leukemia.

Risk of lymphoma subtypes after solid organ transplantation in the United States

D. Weisenburger, R. Pfeiffer, E. Chang, 2013, British Journal of Cancer.

Clinical Trials and Observations

T. Greiner, D. Weisenburger, J. Vose, 2007 .

Vaccination history and risk of non-hodgkin lymphoma: a population-based, case–control study

D. Weisenburger, A. Evens, H. Lankes, 2009, Cancer Causes & Control.

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

L. Staudt, T. Greiner, D. Weisenburger, 2006, Blood.

A randomized , double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia

L. Staudt, T. Greiner, D. Weisenburger, 2011 .

Clinical Trials and Observations

L. Staudt, T. Greiner, D. Weisenburger, 2007 .

Scientific section: LYMPHOID NEOPLASIA Title: Classification of Non-Hodgkin Lymphoma in Central and South America: a Review of 1028 Cases Authors:

D. Weisenburger, Anamarija M. Perry, Jacques Diebold, 2012 .

Effect of addition of rituximab to CHOP on survival of patients in both the GCB and non-GCB subgroups of diffuse large B-cell lymphoma

W. Chan, T. Greiner, D. Weisenburger, 2007 .